Two hands around a dark blue mug of bone broth on a sunlit kitchen table

What two very different health journeys have in common: Junk Protein fails them both

October 28, 2026Patrick Thesing

Bariatric surgery and GLP-1 medications are not the same thing. One is a surgical procedure that permanently restructures digestive anatomy. The other is a pharmaceutical intervention that works through hormone signaling to reduce appetite and regulate blood sugar. The mechanisms are different, the populations overlap but aren't identical, and the clinical management protocols for each are distinct.

And yet from a protein standpoint, they produce remarkably similar challenges. Reduced capacity. Intolerance to conventional protein formats. Elevated need for protein at exactly the moment that getting it in becomes hardest. A population of people who need more from their food than most products were designed to provide.

We didn't set out to build something specifically for these two groups. We built something that works for bodies under nutritional stress, and these are two of the largest and fastest-growing populations in exactly that situation.

Here's what the scale of that looks like — and what we've learned from the people who've found their way to us from both paths.

The scale of the GLP-1 moment

The numbers are large. In November 2025, about 1 in 8 U.S. adults (12%) told KFF they were currently taking a GLP-1 drug for weight loss, diabetes or another condition, up from 18 months earlier. The growth rate has been steep enough that the supply chain struggled to keep pace for much of 2023 and 2024.

The medications work for many people in ways that earlier interventions didn't. Weight loss with GLP-1 medications is associated with reductions in fat mass, lean body mass, and muscle mass that correlate with the degree of body weight reduction — similar to patterns seen with bariatric surgery and very low-calorie diets. PubMed Central Significant weight loss through any mechanism puts muscle at risk, and the appetite suppression that makes GLP-1 medications effective also reduces the dietary protein intake needed to protect that muscle.

The GI side effects compound the problem. Clinical trial data shows gastrointestinal adverse events developing in 40 to 70% of patients on GLP-1 medications, with nausea consistently the most frequent. PubMed Central Nausea doesn't just affect how someone feels — it changes what they can eat, how much they can eat, and how reliable their intake is day to day. For many people, sickly sweet protein shakes become intolerable during GLP-1 treatment in a way they weren't before, a change that appears to have both mechanical and sensory components. The result is that protein needs stay elevated or increase while the most common protein delivery formats become harder to tolerate.

More than half of GLP-1 users discontinue within a year, and 72% within two years, Healio which means a large group of people are also coming off the medication, and their protein needs don't stop when the prescription does.

The bariatric reality

U.S. surgeons performed about 280,000 bariatric procedures in 2022, according to ASMBS estimates. The protein requirements post-surgery are significant and non-negotiable — the American Society for Metabolic and Bariatric Surgery recommends a minimum of 60 grams daily, with optimal ranges often reaching 80 grams or more depending on the procedure and the patient. Meeting those targets is the difference between recovering with preserved lean mass and losing the muscle you need for a sustainable long-term outcome.

The challenge is that surgery fundamentally changes the capacity and sensitivity of the digestive system. Within the first three months after bariatric surgery, 55% of lean body mass loss typically occurs, with more than 8 kilograms of fat-free mass lost in the first year and the predictive score for sarcopenia rising from 8% to 32%. ASPEN The window when protein intake matters most is also the window when the stomach is smallest, most sensitive, and most likely to reject conventional protein formats.

Thick, high-volume, artificially sweetened protein shakes — the standard recommendation in many post-bariatric protocols — frequently become problematic in ways patients don't anticipate. The restructured stomach can't handle the volume. The sweetness that was tolerable before surgery becomes overwhelming or nauseating after it. People cycle through products searching for something their body will accept and that actually hits their protein number, often finding that nothing in the conventional supplement category quite works.

What we're hearing from our customers

It's a pattern that emerged from reviews, from direct customer conversations, and from the specific language people use when they describe why Brite Start restorative protein works for them. The phrases are consistent enough across both populations to be meaningful: "stays down when nothing else does," "gentle on my digestion," "the only protein I can actually handle," "this is a medical necessity for me."

Weathered hands around a wide white mug as a bone broth puck melts in hot water

The common thread is that they're not buying bone broth for its own sake. They're buying something that delivers real protein — 20 grams per serving — in a format that doesn't fight a body that's been through something significant. The warm, savory, small-volume broth format works because it's the opposite of the thick, artificially sweetened shakes that were failing them.

Several customers describe discovering Brite Start bone broth after exhausting other options — after months of trying different powders, different shakes, different bars, all of which either caused GI distress or simply didn't stay down. The gel puck solved a problem the supplement category wasn't built to solve because the supplement category was built around healthy people optimizing performance, not people rebuilding basic nutritional function after medical disruption.

Where restorative protein fits

We want to be direct about what Brite Start is and isn't. It's food — slow-simmered whole bone broth concentrated into a gel puck — and it's not a medical treatment or a replacement for the nutritional counseling that both GLP-1 users and post-bariatric patients should be receiving from their care teams. The protein and collagen in our pucks are real and meaningful. A May 2025 joint advisory from four medical and nutrition societies lists adequate protein among eight nutrition priorities for people on GLP-1 medications. But none of this substitutes for working with a registered dietitian who understands the specific demands of your situation.

What we can say, based on the research and on what our customers tell us, is that format matters as much as ingredients for these populations — and that a small-volume, warm, savory, restorative protein source fills a gap that Junk Protein largely hasn't addressed.

The information in this post is for educational purposes only. Nothing here is intended as medical advice or as a substitute for guidance from your healthcare provider. Always consult a qualified healthcare professional before making changes to your diet or health regimen, particularly if you are currently taking medication or recovering from surgery.

More articles